MPI offers a wide spectrum of services and expertise in scientific, professional, manufacturing, quality control, and regulatory fields in compliance with applicable cGMP/GLP regulations mandated by the FDA.

Services include formulation development, drug delivery design, analytical method development/validation, drug stability assessment, clinical supply manufacturing, labeling, packaging, and shipping. For small scale isolation, extraction, and purification of drug moieties, the company possesses state-of-the-art supercritical fluid (SCF) units. In addition, MPI provides documentation and regulatory support for DMF preparations as well as IND, NDA, and ANDA submissions.

Through scientific collaboration and strategic partnerships, MPI has conducted patentable research and developed several proprietary drug products and delivery systems, including:

  • Microencapsulation
  • Controlled release
  • Sublingual
  • Transdermal gels